Phenotypically driven subgroups of ASD display distinct metabolomic profiles

Area of Science:

• Metabolomics
• Neurodevelopmental Disorders
• Genetics and Genomics

Background:

• Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition with significant phenotypic variability.
• The underlying biological mechanisms contributing to diverse ASD presentations remain poorly understood.
• Understanding ASD heterogeneity is crucial given its global prevalence of approximately 1 in 100 children.

Purpose of the Study:

• To derive phenotypically distinct subgroups within a large cohort of individuals with ASD.
• To investigate the plasma metabolomic profiles of these subgroups to uncover potential biological differences.
• To explore the relationship between specific metabolic patterns and ASD characteristics.

Main Methods:

• Utilized phenotypic and diagnostic data from 2001 individuals (aged 4-17 years) from the Simons Simplex Collection.
• Applied hierarchical clustering on 40 phenotypes across four clinical domains to identify subgroups.
• Performed global plasma metabolomic profiling using ultrahigh-performance liquid chromatography-mass spectrometry (UHPLC-MS).

Main Results:

• Identified three distinct ASD subgroups based on phenotype patterns.
• Subgroup 1 (least maladaptive traits) showed decreased lipids and increased amino acid/nucleotide metabolites.
• Subgroup 2 (most challenges) displayed aberrant lipid metabolism and increased lipid oxidation products.
• Subgroup 3 (maladaptive behaviors, high IQ) exhibited increased sphingolipids and fatty acid byproducts.

Conclusions:

• Distinct metabolic profiles correlate with specific phenotypic subgroups in ASD.
• These metabolic differences may reflect underlying biological mechanisms driving ASD heterogeneity.
• Findings suggest potential for developing personalized medicine strategies for ASD symptom management.